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Introduction: Lymph node involvement is one of the most important
prognostic factors in cancer patients. It is categorized based on the
anatomic extent, but differences in node involvement patterns are not
incorporated in the tumor, node, metastasis classification. Squamous
cell carcinoma more frequently arises in the central airway and invades
adjacent lymph nodes directly than the other histologic types. The
purpose of this study was to evaluate the prognostic impact of lymph
node involvement patterns in pulmonary pN1 SCC patients.
Methods: We reviewed 120 consecutive patients with completely
resected pN1 squamous cell carcinoma and classified them into two
groups based on node involvement pattern: direct (all metastatic N1
nodes involved directly by the main tumor) and separate (one or
more metastatic N1 nodes not directly involved by the main tumor)
N1 groups. To compare the survival probability, 302 pN0 patients
and 59 pN2 patients were also investigated.
Results: Univariate and multivariate analyses showed that the N1
node involvement pattern significantly associated with patient prog-
nosis. The direct N1 group resulted in a much better 5-year overall
survival rate of 67.7% compared with 32.4% for the separate N1
group (p  0.01). The direct N1 group survival curve almost
overlapped with the pN0 curve (p  0.68), whereas the separate N1
group curve overlapped with the pN2 curve (p  0.91).
Conclusions: Direct N1 metastatic cases are highly curable, similar
to pN0 patients. In contrast, separate N1 metastatic cases are
destined to poor prognosis similar to pN2 patients.
(J Thorac Oncol. 2010;5: 504–509)
Lymph node involvement is one of the most importantprognostic factors in cancer patients and is categorized
based on the anatomic extent by the N classification in the
tumor, node, metastasis (TNM) classification of the Union
Internationale Contre le Cancer.1 For lung cancer, the Inter-
national Association for the Study of Lung Cancer has pro-
posed a new lymph node map, reconciling the Naruke et al.2
and American Joint Committee on Cancer3 maps for the 7th
edition of the TNM classification.4 However, nothing has
been suggested regarding N1 (peribronchial, interlobar, or
perihilar) lymph node involvement patterns. To metastasize
to a lymph node separate from the primary tumor, cancer
cells have to invade lymphatic ducts, travel along the lym-
phatic flow, and implant in the lymph node tissue, whereas
direct involvement of an adjacent node is probably simple
invasion. The prognostic impact of node involvement directly
by the main tumor may be different from that of involved
node separate from the primary tumor.
Squamous cell carcinoma (SCC) accounts for approxi-
mately 30% of all lung cancers and is the second most common
histologic type of lung cancer, following adenocarcinoma.5 SCC
arises in central airways adjacent to hilar lymph nodes, more
frequently than the other histologic types.6–8 Lymph nodes
directly involved by the main tumor are expected to be more
often observed in SCC than other histologic types.
The purpose of this study was to evaluate the prognos-
tic impact of N1 lymph node involvement patterns in pulmo-
nary SCC patients pathologically classified as N1 (pN1).
PATIENTS AND METHODS
Patients
From July 1992 through December 2005, 2546 consec-
utive primary lung cancer patients underwent surgical resec-
tion at our hospital. Among them, a total of 124 patients
whose resection was considered complete and disease was
pathologically diagnosed as N1 SCC were identified. We
defined complete resection as lobectomy or more extensive
resection with systematic ipsilateral hilar and mediastinal
lymph node dissection and absence of residual cancer both
macroscopically and histologically. Patients who underwent
any preoperative anticancer treatments or a limited resection
less than lobectomy were excluded from this study. After
excluding four patients because of incomplete pathologic
records, the remaining 120 patients were included in this
study. To compare the survival probability, 302 and 59
patients undergoing complete resection during the same pe-
riod for pathologic N0 (pN0) and N2 (pN2) SCC, respec-
tively, were also investigated. We reviewed their medical
records for the following clinicopathologic factors: age, sex,
location, type of resection, pathologic T classification, tumor
size, clinical N classification, node involvement pattern, #10
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node involvement, number of metastatic N1 nodes, lymphatic
permeation, vascular invasion, and pleural invasion.
Histopathologic Evaluation
All surgical specimens were fixed with 10% formalin and
embedded in paraffin. The tumors were sliced at approximately
5-mm intervals, and serial 4-m sections were stained using
hematoxylin and eosin for routine pathologic evaluation and
Elastica-van Gieson or Victoria blue-van Gieson staining
method for elastic fibers. Lymphatic infiltration was considered
to be present when tumor cells were identified floating in
lymphatic vessels defined by the lack of supporting smooth
muscles or elastic fibers in the vessel wall. Vascular invasion
was considered to be present when tumor cells were identified
floating in blood vessels defined by supporting elastic fibers in
the vessel wall. Pleural invasion was considered to be present
when tumor cells were identified beyond the elastic layer of the
visceral pleura regardless of tumor exposure on the pleural
surface.9 Histologic classification of the resected specimens was
determined according to the World Health Organization Inter-
national Histologic Classification of Tumors.5 Lymph nodes
were clinically diagnosed as involved when larger than 1.0 cm in
the shortest axis on preoperative contrast-enhanced computed
tomography (CT). Clinical N classification and pathologic stage
were determined according to the Union Internationale Contre le
Cancer TNM classification.1 Tumor location was defined as
central if the primary tumor arose in the main bronchus or
segmental bronchi and as peripheral if the primary tumor was
located distally to the subsegmental bronchi.
Lymph Node Involvement
Lymph node stations were designated according to
the lymph node map by Naruke et al.,2 and #10 nodes were
defined as main bronchial nodes. We classified N1 involve-
ment into two patterns according to the relationship between
the main tumor and N1 node on resected specimens. We
defined a “direct N1” node as an N1 node completely inside
of, or partly connected to, the primary tumor (Figures 1A, B).
Because the resected specimens were sliced at approximately
5-mm intervals, N1 nodes, which were 3 mm or less apart
from the main tumor, were also classified as direct N1 even
if the tumor did not seem to be in direct contact with the N1
nodes on the resected specimen. The other pattern, a “sepa-
rate N1” node, was defined as an N1 node connected with the
primary tumor only by preexisting normal bronchovascular
structure and located more than 3 mm away from the main
tumor (Figures 1C, D). We classified the 120 pN1 patients
into two groups: patients whose involved N1 nodes were all
direct N1 nodes as the direct group and those with at least one
separate N1 node as the separate group.
Statistical Analysis
The N1 node involvement patterns and clinicopatho-
logic factors were analyzed for correlation by the 2 test or
FIGURE 1. Patterns of N1 involve-
ment according to the relationship
between the main tumor and in-
volved node on resected specimen.
Macroscopic (A) and microscopic
(hematoxylin and eosin; B) findings
of the main tumor and “direct N1”
nodes. N1 nodes are completely
inside of, or partly connected to,
the main tumor. Macroscopic find-
ings of the main tumor and “sepa-
rate N1” node (C) and microscopic
findings of the node (hematoxylin
and eosin; D).
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Fisher’s exact test, as appropriate. Cox’s proportional hazards
regression model was used to identify statistically significant
differences in survival and estimate hazard ratios and 95%
confidence intervals. Survival curves were plotted using the
Kaplan-Meier method, and the statistical significances of
differences between subgroups were determined using the
log-rank test. The end point for analyses was overall survival,
measured from the date of surgery to the date of death, from
any cause. The last follow-up observation was censored when
the patient was alive or lost to follow-up. All p values were
two-sided and p values less than 0.05 were considered statis-
tically significant. Statistical analysis software (Dr. SPSS II
for Windows, standard Version 11.0, SPSS Inc., Chicago, IL)
was used for these analyses. Data collection and analyses
were approved, and the need for obtaining informed consent
from each patient was waived by the institutional review
board in August 2009.
RESULTS
N1 Node Involvement Patterns and
Clinicopathologic Factors
The clinicopathologic characteristics of the 120 pN1
patients are shown in Tables 1 and 2, and the correlations
TABLE 1. Clinicopathologic Characteristics of pN1
SCC Patients
%
No. of patients 120
Age (mean) 49–83 (65)
Sex
Female 8 7
Male 112 93
Location
Central 73 61
Peripheral 47 39
Type of resection
Lobectomy 62 52
Bilobectomy 17 14
Pneumonectomy 41 34
pT classification
T1 20 17
T2 63 52
T3 31 26
T4 6 5
Tumor size (cm)
3 27 23
3, 5 53 44
5 40 33
cN classification
N0 60 50
N1 56 47
N2 4 3
Lymphatic infiltration
Absent 57 48
Present 63 52
Vascular invasion
Absent 18 15
Present 102 85
Pleural invasion
Absent 66 55
Present 54 45
SCC, squamous cell carcinoma.
TABLE 2. Pathologic Characteristics of N1 Node Involvement
%
No. of patients 120
Node involvement pattern
Direct 80 67
Separate 40 33
#10 node involvement
Present 18 15
Absent 102 85
Number of metastatic N1 nodes
Single 56 47
Multiple 64 53
TABLE 3. Correlations Between Node Involvement Patterns
and Clinicopathologic Factors
Node Involvement
Pattern
pDirect Separate
Age
65 36 17
65 44 23 0.85
Location
Central 64 9
Peripheral 16 31 0.01
cN classification
N0 38 22
N1–2 42 18 0.82
pT classification
T1 12 8
T2 43 20
T3 21 10
T4 4 2 0.94
Tumor size (cm)
5 59 21
5 21 19 0.02
#10 node involvement
Present 9 9
Absent 71 31 0.11
Number of metastatic N1 nodes
Single 38 18
Multiple 42 22 0.85
Lymphatic infiltration
Absent 40 17
Present 40 23 0.56
Vascular invasion
Absent 15 3
Present 65 37 0.17
Pleural invasion
Absent 50 16
Present 30 24 0.03
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between the node involvement patterns and other clinicopath-
ologic factors are shown in Table 3. We chose 5.0 cm as the
tumor size cutoff, because the median tumor size was 4.2 cm
and 5 cm is one of the tumor size cutoffs in the 7th edition of
the TNM classification.10 Because the median number of
metastatic N1 node was 2, we divided the patients into single
or multiple node involvement groups. The direct N1 node
involvement pattern was significantly correlated with central
location, larger size, and positive pleural invasion of the main
tumor.
Prognostic Impact of N1 Node Involvement
Pattern on Survival
The median length of overall follow-up period for the
censored patients was 5.4 years. Univariate analyses showed that
patient survival significantly associated with N1 node involve-
ment pattern, as well as the location and vascular invasion, and
marginally associated with tumor size and pleural invasion
(Table 4). Among these 5 factors, multivariate analysis proved
that the separate N1 node involvement pattern was the only
independent predictor of poor outcome (hazard ratio: 1.839,
95% confidence interval: 1.015–3.333; Table 5).
Survival curves are shown in Figure 2. The 5-year overall
survival rate of pN1 patients (55.7%) was marginally lower than
that of pN0 patients (61.7%, p  0.05) and significantly higher
than that of pN2 patients (25.5%, p  0.01; Figure 2A). When
FIGURE 2. Overall survival curves of pN0-2 pulmonary SCC
patients. Overall survival curves of all pN0, pN1, and pN2
patients (A). Overall survival curves of the direct and sepa-
rate N1 groups compared with pN0 and pN2 patients (B).
TABLE 4. Prognostic Significance Regarding Overall
Survival (Univariate Analysis)
Cases 5 yr (%) p
Age
65 53 53.2
65 67 57.5 0.98
Sex
Female 8 57.1
Male 112 55.7 0.78
Location
Central 73 64.9
Peripheral 47 41.9 0.01
Type of resection
Lobectomy, bilobectomy 79 54.7
Pneumonectomy 41 58.4 0.73
pT classification
T1–2 83 59.2
T3–4 37 47.3 0.18
Tumor size (cm)
5 80 59.2
5 40 48.0 0.12
Node involvement pattern
Direct 80 67.7
Separate 40 32.4 0.01
#10 node involvement
Absent 102 59.0
Present 18 38.9 0.16
Number of metastatic N1 nodes
Single 56 60.3
Multiple 64 51.9 0.83
Absent 57 61.7
Present 63 50.5 0.36
Vascular invasion
Absent 18 77.4
Present 102 51.7 0.01
Pleural invasion
Absent 66 62.2
Present 54 47.3 0.11
TABLE 5. Prognostic Significance on Overall Survival
(Multivariate Analysis)
Cases HR 95% CI p
Tumor size (cm)
5 80 1
5 40 1.387 0.716–2.686 0.33
Location
Central 73 1
Peripheral 47 1.536 0.845–2.792 0.16
Node involvement pattern
Direct 80 1
Separate 40 1.839 1.015–3.333 0.04
Vascular invasion
Absent 18 1
Present 102 2.551 0.876–7.426 0.09
Pleural invasion
Absent 66 1
Present 54 1.119 0.578–2.165 0.74
HR, hazard ratio; CI, confidence interval.
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the direct and separate N1 groups were compared, the direct N1
group had a much better 5-year overall survival rate of 67.7%
compared with 32.4% of the separate N1 group, and the log-rank
test showed statistically significant difference (p  0.01; Figure
2B). The direct N1 group survival curve almost overlapped with
the pN0 curve, whereas the separate N1 group curve overlapped
with the pN2 curve (log-rank test: p  0.679 and 0.914,
respectively; Figure 2B).
Figure 3 shows the results of stratified analysis accord-
ing to pathologic T classification. In pT2 and pT3 patients,
the direct N1 group showed significantly better outcomes
than the separate N1 group (p  0.01 and 0.01, respec-
tively; Figures 3B, C). Although significance was not reached
in pT1 patients (p  0.17; Figure 3A), this was probably due
to the small number of patients in each group.
In 80 direct N1 patients, 42 (53%) had more than two
involved N1 nodes, but the 5-year overall survival rate of
these multiple node involvement patients (62%) was compa-
rable with that of the 38 single node involvement patients
(74%, p  0.64).
DISCUSSION
N1 nodes in lung cancer patients include peribronchial,
interlobar, and perihilar lymph nodes. The survival probabil-
ity of pN1 patients is evidently lower than that of pN0
patients, and adjuvant chemotherapy is recommended after
complete resection.11–13 The reported 5-year survival rates of
pN1 patients range from 38% to 67%.14–19 The wide range
suggests that pN1 patients are heterogeneous, and various prog-
nostic factors have been reported. In the previous studies, pN1
node involvement pattern was reported to be associated with
patient prognosis.16,17,20–22 van Velzen et al.20–22 analyzed the
association between pN1 involvement patterns and non-small
cell lung cancer (NSCLC) patient survival in T1, T2, and T3-4
patients separately. They found significant association only in
pT1N1M0 patients but did not compare them with pN0 or pN2
patients. In their study, the prognostic impact of lymph node
involvement patterns in comparison with the other nodal in-
volvement classifications was not clarified.
In our current study, the overall survival rates were
significantly different between the direct and separate pN1
groups for all patients, pT2 patients, and also for pT3 pa-
tients. The direct group outcome was comparable with that of
pN0 patients. In this group, N1 involvement may be due to
direct cancer invasion and not due to cancer cells exfoliated
and transported by lymphatic flow. Although they are classi-
fied as pN1, the main tumor and involved nodes may remain
local without lymphatic extension, and when completely
resected, the disease is expected to be highly curable. In
contrast, the separate N1 group outcome was as poor as that
of pN2 patients. In this group, although cancer cells were not
observed in the dissected mediastinal lymph nodes, cancer
cells may have been transported further by lymphatic flow.
Separate N1 status may be a sign of systemic disease and
result in an outcome similar to pN2 disease.
Centrally located SCC and peripheral SCC have been
reported to differ in clinicopathologic and biologic characters
but not in survival.7,8 In our study, survival was significantly
FIGURE 3. Stratified analysis of
prognostic impact of node involve-
ment pattern according to patho-
logic T classification. Overall survival
curves of the direct and separate N1
groups in pT1 (A), pT2 (B), and pT3
(C) patient groups.
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different between these two groups in univariate analysis but
not in multivariate analysis. There were more direct pN1
patients in the centrally located group than in the peripherally
located group. The node involvement pattern and main tumor
location (central versus peripheral) significantly correlated
(p  0.01). These results suggest that better survival of
centrally located pN1 SCC patients compared with peripheral
patients in our series may be explained by the predominance
of direct pN1 pattern in the centrally located group.
In pN1 NSCLC patients, #10 node involvement has
been reported to be a poor prognostic factor.17–19 Although
#10 node involvement was not associated with poor survival
in our study, the 5-year overall survival rate was significantly
higher in patients with direct #10 node involvement (66.7%,
n  9) than in patients with separate #10 node involvement
(0%, n 9, p 0.02). The number of patients was small, but
these results may strengthen the suggestion that node involve-
ment through lymphatic flow, separate N1, has stronger
unfavorable impact on survival than node involvement by
direct invasion, direct N1.
The number of involved nodes has been reported to be
associated with poor patient outcome in pN1-2 NSCLC
patients.23–25 In our study, however, there was no significant
difference in survival between single and multiple node
involvement patients. In the direct N1 group, the 5-year
overall survival rate of multiple node involvement patients
was comparable with that of single node involvement pa-
tients. In direct N1 group, when complete resection is per-
formed, a favorable outcome can be expected even if multiple
nodes are involved.
CONCLUSIONS
Lymph node involvement pattern had significant out-
come impact on pulmonary pN1 SCC patients. The direct N1
group outcome was comparable with that of pN0 patients,
whereas the separate N1 group outcome was as poor as pN2
patients. These results suggest that direct N1 disease is local
and separate N1 disease is systemic, although they are cur-
rently categorized in the same N1 classification. Further study
including other histologic type is essential to verify our
findings and to incorporate N1 involvement pattern in future
NSCLC staging systems.
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